STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENVB
  4. [EFFECT] Enveric Biosciences, Inc. SEC Filing

[EFFECT] Enveric Biosciences, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 17, 2026 5:00 P.M.
Form: S-1
CIK: 0000890821
Company Name: Enveric Biosciences, Inc.
File Number: 333-293327

Source: View Original Filing on SEC EDGAR

Stock ENVB logo
Enveric Biosciences Inc

NASDAQ:ENVB

ENVB Rankings

#6832 Ranked by Market Cap
N/A Ranked by Dividends

ENVB Latest News

Jan 29, 2026
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
Jan 28, 2026
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Jan 28, 2026
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Dec 29, 2025
Enveric Biosciences Announces Patent Issuance
Dec 15, 2025
ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

ENVB Latest SEC Filings

Feb 18, 2026
[424B3] Enveric Biosciences, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Feb 9, 2026
[S-1] Enveric Biosciences, Inc. Files IPO Registration Statement
Feb 6, 2026
[8-K] Enveric Biosciences, Inc. Reports Material Event
Feb 6, 2026
[424B5] Enveric Biosciences, Inc. Prospectus Supplement (Debt Securities)
Feb 4, 2026
[SCHEDULE 13G] Enveric Biosciences, Inc. Passive Investment Disclosure (>5%)

ENVB Stock Data

2.92M
1.32M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE